Overview
Roxadustat as an innovative inhibitor of hypoxia-inducible factor prolyl hydroxylase, specifically designed for managing anemia linked to chronic kidney disease.
Roxastat
- Generic Name
- Roxadustat
- Therapeutic Area
- Nephrology
- Therapeutic Class
- Antianemic – HIF-PH Inhibitor
- Dosage Form
- Tablets
- Strength
- 20 mg, 50 mg, 100 mg & 150 mg
- Pack Size
- 10's
- Registration Number
- 120201, 120202, 120203, 125350 & 125351
Indication
Roxastat is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (CKD).
